1. Home
  2. AEIS vs CRSP Comparison

AEIS vs CRSP Comparison

Compare AEIS & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AEIS
  • CRSP
  • Stock Information
  • Founded
  • AEIS 1981
  • CRSP 2013
  • Country
  • AEIS United States
  • CRSP Switzerland
  • Employees
  • AEIS N/A
  • CRSP N/A
  • Industry
  • AEIS Industrial Machinery/Components
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AEIS Technology
  • CRSP Health Care
  • Exchange
  • AEIS Nasdaq
  • CRSP Nasdaq
  • Market Cap
  • AEIS 5.3B
  • CRSP 4.9B
  • IPO Year
  • AEIS 1995
  • CRSP 2016
  • Fundamental
  • Price
  • AEIS $148.73
  • CRSP $51.83
  • Analyst Decision
  • AEIS Buy
  • CRSP Buy
  • Analyst Count
  • AEIS 10
  • CRSP 16
  • Target Price
  • AEIS $140.70
  • CRSP $72.27
  • AVG Volume (30 Days)
  • AEIS 494.6K
  • CRSP 2.5M
  • Earning Date
  • AEIS 10-29-2025
  • CRSP 08-04-2025
  • Dividend Yield
  • AEIS 0.27%
  • CRSP N/A
  • EPS Growth
  • AEIS N/A
  • CRSP N/A
  • EPS
  • AEIS 2.22
  • CRSP N/A
  • Revenue
  • AEIS $1,635,742,000.00
  • CRSP $38,050,000.00
  • Revenue This Year
  • AEIS $19.29
  • CRSP $11.17
  • Revenue Next Year
  • AEIS $7.24
  • CRSP $296.09
  • P/E Ratio
  • AEIS $67.44
  • CRSP N/A
  • Revenue Growth
  • AEIS 8.49
  • CRSP N/A
  • 52 Week Low
  • AEIS $75.01
  • CRSP $30.04
  • 52 Week High
  • AEIS $163.08
  • CRSP $71.13
  • Technical
  • Relative Strength Index (RSI)
  • AEIS 58.39
  • CRSP 40.26
  • Support Level
  • AEIS $151.62
  • CRSP $51.80
  • Resistance Level
  • AEIS $156.91
  • CRSP $55.30
  • Average True Range (ATR)
  • AEIS 4.77
  • CRSP 2.23
  • MACD
  • AEIS -0.31
  • CRSP -0.58
  • Stochastic Oscillator
  • AEIS 57.24
  • CRSP 4.66

About AEIS Advanced Energy Industries Inc.

Advanced Energy Industries Inc provides precision power-conversion measurement and control solutions that transform power into various forms for use in manufacturing and industrial equipment and applications. The firm serves original equipment manufacturers and end customers in the semiconductor, flat panel display, solar panel, and other industrial capital equipment markets. Products include thin-film power-conversion systems, which control and modify raw electrical power into a customizable, predictable power source, and power control modules, which control and measure temperature during manufacturing cycles. A majority of the firm's revenue is generated in United States, with the rest from Mexico, Taiwan, China and All others.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: